Chemoradiation therapy in patients (pts) with small cell lung cancer (SCLC) with pericardial effusion but no distant metastasis
Abstract only 7555 Background: Our previous retrospective analysis demonstrated that the survival of the limited-disease (LD) SCLC pts with ipsilateral pleural effusion was intermediate between those of LD pts without ipsilateral pleural effusion and extensive-disease (ED) pts, and that long-term su...
Saved in:
Published in | Journal of clinical oncology Vol. 27; no. 15_suppl; p. 7555 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
20.05.2009
|
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract only
7555
Background: Our previous retrospective analysis demonstrated that the survival of the limited-disease (LD) SCLC pts with ipsilateral pleural effusion was intermediate between those of LD pts without ipsilateral pleural effusion and extensive-disease (ED) pts, and that long-term survival was achieved by LD-SCLC pts with ipsilateral pleural effusion who successfully underwent chemoradiotherapy (CRT) (J Thorac Oncol 2008;3:723–7). We retrospectively investigated the clinical course and outcome in pts with SCLC with pericardial effusion but no distant metastasis and examined the overall survival in pts who received chemotherapy and definitive thoracic radiotherapy (TRT). Methods: The medical records of SCLC pts who received treatment at the National Cancer Center Hospital East between July 1992 and December 2007 were reviewed. During this period 767 pts were newly diagnosed as having SCLC. Four-hundred seventeen pts had no distant metastasis. Ninety-six of those 417 pts (23%, 95% confidence interval (CI): 19–27%) had pleural or pericardial effusion or disseminated pleural nodules, and were included in this study. The 96 pts were divided into two groups: group A included pts with pericardial effusion (n=33), and group B included pts who had pleural effusion and/or disseminated pleural nodules, but did not have pericardial effusion (n=63). Sixteen pts had both pleural and pericardial effusion. Results: All but one patient received systemic chemotherapy. A remaining patient with pleural effusion received only best supportive care. In group A, 19 pts received chemoradiotherapy. TRT was conducted concurrently with 3 or 4 cycles of chemotherapy in 12 pts and sequentially in 7 pts. The response rate for first-line chemotherapy was 79%. In group B, 26 pts received chemoradiotherapy. Survival data were shown as below. Conclusions: Long-term survival was seldom achieved by SCLC pts with pericardial effusion but no distant metastasis, even if they underwent chemoradiotherapy.
[Table: see text]
No significant financial relationships to disclose. |
---|---|
AbstractList | Abstract only
7555
Background: Our previous retrospective analysis demonstrated that the survival of the limited-disease (LD) SCLC pts with ipsilateral pleural effusion was intermediate between those of LD pts without ipsilateral pleural effusion and extensive-disease (ED) pts, and that long-term survival was achieved by LD-SCLC pts with ipsilateral pleural effusion who successfully underwent chemoradiotherapy (CRT) (J Thorac Oncol 2008;3:723–7). We retrospectively investigated the clinical course and outcome in pts with SCLC with pericardial effusion but no distant metastasis and examined the overall survival in pts who received chemotherapy and definitive thoracic radiotherapy (TRT). Methods: The medical records of SCLC pts who received treatment at the National Cancer Center Hospital East between July 1992 and December 2007 were reviewed. During this period 767 pts were newly diagnosed as having SCLC. Four-hundred seventeen pts had no distant metastasis. Ninety-six of those 417 pts (23%, 95% confidence interval (CI): 19–27%) had pleural or pericardial effusion or disseminated pleural nodules, and were included in this study. The 96 pts were divided into two groups: group A included pts with pericardial effusion (n=33), and group B included pts who had pleural effusion and/or disseminated pleural nodules, but did not have pericardial effusion (n=63). Sixteen pts had both pleural and pericardial effusion. Results: All but one patient received systemic chemotherapy. A remaining patient with pleural effusion received only best supportive care. In group A, 19 pts received chemoradiotherapy. TRT was conducted concurrently with 3 or 4 cycles of chemotherapy in 12 pts and sequentially in 7 pts. The response rate for first-line chemotherapy was 79%. In group B, 26 pts received chemoradiotherapy. Survival data were shown as below. Conclusions: Long-term survival was seldom achieved by SCLC pts with pericardial effusion but no distant metastasis, even if they underwent chemoradiotherapy.
[Table: see text]
No significant financial relationships to disclose. |
Author | Ohmatsu, H. Niho, S. Goto, K. Kubota, K. Saijo, N. Yoh, K. Nishiwaki, Y. |
Author_xml | – sequence: 1 givenname: S. surname: Niho fullname: Niho, S. organization: National Cancer Center Hospital East, Kashiwa, Japan – sequence: 2 givenname: K. surname: Kubota fullname: Kubota, K. organization: National Cancer Center Hospital East, Kashiwa, Japan – sequence: 3 givenname: K. surname: Yoh fullname: Yoh, K. organization: National Cancer Center Hospital East, Kashiwa, Japan – sequence: 4 givenname: K. surname: Goto fullname: Goto, K. organization: National Cancer Center Hospital East, Kashiwa, Japan – sequence: 5 givenname: H. surname: Ohmatsu fullname: Ohmatsu, H. organization: National Cancer Center Hospital East, Kashiwa, Japan – sequence: 6 givenname: N. surname: Saijo fullname: Saijo, N. organization: National Cancer Center Hospital East, Kashiwa, Japan – sequence: 7 givenname: Y. surname: Nishiwaki fullname: Nishiwaki, Y. organization: National Cancer Center Hospital East, Kashiwa, Japan |
BookMark | eNqljzFPwzAQhS1UJNLCfzi2MiTYCZbbOQIxsMHAZrmuQ1w5tuVzhDrx13Gk8gtY7t2d3nvStyYrH7wh5J7RhrWUPp50aIrum1Y0jEucY3SN4JxfkYrxVtSiHCtSUdG1Ndt1nzdkjXiilD3tOl6Rn340U0jqaFW2wUMeTVLxDNZDLB_jM8I2ZnyAb5tHwEk5B9qU4Wb_BVp5bRJs3_u3_mKJJlmtUil0YIZhxqX2MGfwAY4Ws_IZJpNV2dDiLbkelENzd9EN2b88f_SvtU4BMZlBxmQnlc6SUbkQy0IsF2LZCvlHLBfi7j_ZX2FBahE |
ContentType | Journal Article |
DBID | AAYXX CITATION |
DOI | 10.1200/jco.2009.27.15_suppl.7555 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1527-7755 |
EndPage | 7555 |
ExternalDocumentID | 10_1200_jco_2009_27_15_suppl_7555 |
GroupedDBID | --- .55 0R~ 18M 2WC 34G 39C 3O- 4.4 53G 5GY 5RE 8F7 8WZ A6W AARDX AAWTL AAYEP AAYOK AAYXX ABJNI ABOCM ACGFO ACGFS ACGUR ADBBV AEGXH AENEX AFFNX AI. AIAGR ALMA_UNASSIGNED_HOLDINGS AWKKM BAWUL C45 CITATION CS3 DIK EBS EJD F5P F9R FBNNL FD8 GX1 H13 HZ~ IH2 KQ8 L7B LSO MJL N4W N9A O9- OK1 OVD OWW P2P QTD R1G RHI RLZ RUC SJN SV3 TEORI TR2 TWZ UDS VH1 VVN WH7 X7M YCJ YFH YQY |
ID | FETCH-crossref_primary_10_1200_jco_2009_27_15_suppl_75553 |
ISSN | 0732-183X |
IngestDate | Fri Aug 23 01:50:55 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 15_suppl |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-crossref_primary_10_1200_jco_2009_27_15_suppl_75553 |
ParticipantIDs | crossref_primary_10_1200_jco_2009_27_15_suppl_7555 |
PublicationCentury | 2000 |
PublicationDate | 2009-05-20 |
PublicationDateYYYYMMDD | 2009-05-20 |
PublicationDate_xml | – month: 05 year: 2009 text: 2009-05-20 day: 20 |
PublicationDecade | 2000 |
PublicationTitle | Journal of clinical oncology |
PublicationYear | 2009 |
SSID | ssj0014835 |
Score | 3.9392185 |
Snippet | Abstract only
7555
Background: Our previous retrospective analysis demonstrated that the survival of the limited-disease (LD) SCLC pts with ipsilateral pleural... |
SourceID | crossref |
SourceType | Aggregation Database |
StartPage | 7555 |
Title | Chemoradiation therapy in patients (pts) with small cell lung cancer (SCLC) with pericardial effusion but no distant metastasis |
Volume | 27 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JS8NQEH7UCuJFXHFnBBGlJtaXxJijFBfcEKzQW0hiSiuaFNsc6sW_5k9z5i1J6oLLJaSP1yHJfMzMm5WxzSBw9--9MMRjie0YtsVjI0C9YNRjNI7rYcTdQHT7vD44u7PPW06rUnkrZS1lg9CMXr6sK_kPV3EN-UpVsn_gbE4UF_Ae-YtX5DBef8VjqvZHFt7Lz1uTtVSikE-1SxUu1R5lSngqGf2JQtHkra89ZlRuS0ynERuHt43LRr6tJ8I4z6KoJG63M3Kp1cJsUEtSCunQ5GGaPR3gXb_b_8bAzYsu0yQacd5fdzvCQXtrFoGkMJVm7IVZyKHO6MJpKkY-6RXtqvAoys7rJYnmWtxAGdKSykdJXO6iiS979WqRLNsFaOg5fp8mnJbELG53Sipb__ykDriYdP0QySpPk7umJmYWJMotuD-oxjxhkY5KSMJHUjS40_O562tSPpEaY-Pc9RxKKj1t5UlGeNaUI171i0-wDfVce98-VclCKpk6zWk2pVgIRxJwM6wSJ7Ns4kplYcyyrRvZ73y4C82ifK-_C1twU3RCH86x11GAggIodBPQAIVthOcOEOpAgBMInEDgBAlO2CZoqi0lYIIGJiAwIUlBARMKYM4z7-S42Tgz9Jv6Pdlcxf_xS1sLrJqkSbzIIDiMHRFH51Fku3T4d9rtwLapp54VWPtLjP-d_vJ__rTCJgvAr7Lq4DmL19BaHYTrAhDvCACaJw |
link.rule.ids | 315,786,790,27955,27956 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chemoradiation+therapy+in+patients+%28pts%29+with+small+cell+lung+cancer+%28SCLC%29+with+pericardial+effusion+but+no+distant+metastasis&rft.jtitle=Journal+of+clinical+oncology&rft.au=Niho%2C+S.&rft.au=Kubota%2C+K.&rft.au=Yoh%2C+K.&rft.au=Goto%2C+K.&rft.date=2009-05-20&rft.issn=0732-183X&rft.eissn=1527-7755&rft.volume=27&rft.issue=15_suppl&rft.spage=7555&rft.epage=7555&rft_id=info:doi/10.1200%2Fjco.2009.27.15_suppl.7555&rft.externalDBID=n%2Fa&rft.externalDocID=10_1200_jco_2009_27_15_suppl_7555 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0732-183X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0732-183X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0732-183X&client=summon |